The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Kalydeco

150 milligram(s) Film-coated tablet

Vertex Pharmaceuticals (U.K.) LimitedEU/1/12/782/001-002

Main Information

Trade NameKalydeco
Active SubstancesIvacaftor
Strength150 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderVertex Pharmaceuticals (U.K.) Limited
Licence NumberEU/1/12/782/001-002

Group Information

ATC CodeR07AX02 ivacaftor

Status

Authorised/WithdrawnAuthorised
Licence Issued23/07/2012
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back